Screener
Charles River Laboratories CRL Goodwill impairment
Goodwill impairment at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Fiscal Year / 2025 | Fiscal Year / 2024 | Fiscal Year / 2023 |
|---|---|---|---|
| Selling, general and administrative | 743,073 | 751,003 | 747,855 |
| Amortization of intangible assets | 179,066 | 138,471 | 137,440 |
| Intangible asset impairment | 210,974 | — | — |
| Goodwill impairment | 165,000 | 215,000 | — |
| Operating income | 25,162 | 227,347 | 617,261 |
| Other income (expense) | |||
| Interest income | 4,940 | 8,575 | 5,196 |
| Interest expense | (107,029) | (126,288) | (136,710) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's goodwill impairment?
- Charles River Laboratories (CRL) reported goodwill impairment of $41.25M in Q4 2025.
- How has Charles River Laboratories's goodwill impairment changed year-over-year?
- Charles River Laboratories's goodwill impairment decreased by 23.3% year-over-year, from $53.75M to $41.25M.
- What does goodwill impairment mean?
- Write-down of goodwill carrying value when a reporting unit's fair value falls below its book value, indicating that past acquisitions have lost value.
Ask your AI about Charles River Laboratories's goodwill impairment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude